LGALS3 and carcinoma: In order to evaluate the binding specificity of a 99mTc-labeled mAb to galectin-3 in vivo, six animals bearing galectin-3 positive carcinoma xenografts (ARO-Gal-3+) were considered in a preliminary experiment.